Voyageur Pharmaceuticals Ltd
Market cap
Current P/E
Forward P/E


Health care
Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. focuses on the development of active pharmaceutical ingredients minerals. The company intends to develop barium and iodine radiocontrast products and bromine based pharmaceutical products. It holds 100% interest in three barium sulfate deposits, including two properties suitable in grade for the pharmaceutical barite marketplace located in British Columbia, Canada; and interests in a high-grade iodine, lithium, and bromine brine project in Utah, the United States.

Similar securities

Based on sector and market capitalization

Report issue